S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000

Neumora Therapeutics (NMRA) News Today

$18.42
+0.97 (+5.56%)
(As of 02/9/2024 08:56 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media
SourceHeadline
marketbeat.com logoNeumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Average Rating of "Moderate Buy" from Analysts
marketbeat.com - February 12 at 3:23 AM
seekingalpha.com logoNeumora: Phase 3 MDD Readout In H2-24 Could Get Ball Rolling
seekingalpha.com - February 8 at 7:59 AM
marketbeat.com logoNeumora Therapeutics (NASDAQ:NMRA) Sees Strong Trading Volume
marketbeat.com - February 6 at 12:54 PM
finance.yahoo.com logoNeumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer
finance.yahoo.com - January 22 at 7:27 AM
marketbeat.com logoNeumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Average Recommendation of "Moderate Buy" from Analysts
marketbeat.com - January 18 at 4:44 AM
finance.yahoo.com logoWhy Neumora Therapeutics (NMRA) Stock Might be a Great Pick
finance.yahoo.com - January 10 at 9:58 AM
seekingalpha.com logoNMRA Neumora Therapeutics, Inc.
seekingalpha.com - January 5 at 5:10 PM
finance.yahoo.com logoNeumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 10:18 AM
seekingalpha.com logoNeumora: Novel Neuroscience Player, But Valuation Is Too High
seekingalpha.com - January 2 at 5:14 AM
marketbeat.com logo3,309,124 Shares in Neumora Therapeutics, Inc. (NASDAQ:NMRA) Acquired by WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST
marketbeat.com - December 31 at 11:23 AM
marketbeat.com logoNeumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Average Recommendation of "Moderate Buy" from Brokerages
marketbeat.com - December 24 at 4:17 AM
morningstar.com logoNeumora Therapeutics Inc NMRA
morningstar.com - December 22 at 6:31 PM
msn.com logoBristol-Karuna deal: What other biotechs might be in M&A crosshairs?
msn.com - December 22 at 1:30 PM
benzinga.com logoNeumora Therapeutics Stock (NASDAQ:NMRA) Dividends: History, Yield and Dates
benzinga.com - December 22 at 1:30 PM
finanznachrichten.de logoNeumora Therapeutics, Inc.: Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
finanznachrichten.de - December 12 at 9:04 AM
finance.yahoo.com logoNeumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
finance.yahoo.com - December 12 at 9:04 AM
marketbeat.com logoNeumora Therapeutics (NASDAQ:NMRA) Coverage Initiated by Analysts at Deutsche Bank Aktiengesellschaft
marketbeat.com - December 12 at 8:14 AM
markets.businessinsider.com logoNeumora Therapeutics Begins Phase 1 Study With NMRA-266 - Quick Facts
markets.businessinsider.com - November 27 at 10:19 AM
finance.yahoo.com logoNeumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study
finance.yahoo.com - November 27 at 10:19 AM
benzinga.com logoNeumora Therapeutics Stock (NASDAQ:NMRA), Analyst Ratings, Price Targets, Predictions
benzinga.com - November 9 at 9:56 AM
finanznachrichten.de logoNeumora Therapeutics, Inc.: Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
finanznachrichten.de - November 1 at 1:02 PM
finanznachrichten.de logoNeumora Therapeutics Announces IPO Of 14.71 Mln Shares To Be Priced Between $16.00 And $18.00/Share
finanznachrichten.de - November 1 at 8:01 AM
finance.yahoo.com logoNeumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - November 1 at 8:01 AM
finance.yahoo.com logoNeumora Therapeutics to Participate in Upcoming Conferences in November
finance.yahoo.com - October 30 at 7:21 AM
seekingalpha.com logoNeumora: First Novel Mechanism Of Action Drug In Major Depression In Decades
seekingalpha.com - October 18 at 7:03 PM
in.investing.com logoNeumora Therapeutics started with Buy ratings at several Wall Street firms
in.investing.com - October 10 at 7:13 PM
cnbc.com logoBuy this 'game-changer' biotech stock with more than 50% upside, BofA says
cnbc.com - October 10 at 2:12 PM
markets.businessinsider.com logoWhy Neumora Therapeutics Analysts Are Bullish About Major Depressive Disorder Drug
markets.businessinsider.com - October 10 at 2:12 PM
markets.businessinsider.com logoNeumora Therapeutics: A Promising Buy with Diversified Pipeline and High Upside Potential
markets.businessinsider.com - October 10 at 9:12 AM
finance.yahoo.com logoNeumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development
finance.yahoo.com - October 10 at 9:12 AM
marketbeat.com logoInsider Buying: Neumora Therapeutics, Inc. (NASDAQ:NMRA) Major Shareholder Buys 34,560 Shares of Stock
marketbeat.com - September 29 at 8:19 PM
fool.com logoNeumora Therapeutics (NASDAQ: NMRA)
fool.com - September 21 at 9:40 PM
investing.com logoNeumora Therapeutics Inc (NMRA)
investing.com - September 21 at 4:39 PM
seekingalpha.com logoNeumora Therapeutics Begins U.S. IPO Rollout
seekingalpha.com - August 28 at 12:41 PM
Get Neumora Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRA and its competitors with MarketBeat's FREE daily newsletter.



NMRA Media Mentions By Week

NMRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NMRA
News Sentiment
▼
0.97

0.92
▲
Average
Medical
News Sentiment

NMRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NMRA Articles
This Week
▼
3

1
▲
NMRA Articles
Average Week

Get Neumora Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:NMRA) was last updated on 2/12/2024 by MarketBeat.com Staff

My Account -